AIVL’s advocacy and engagement work includes the development of policy
statements and submissions on issues of relevance to people who use/have used drugs.

Policies

Image

Policy Statement on Custodial Settings and hepatitis C: Harm Reduction and Continuity of Care

Image

Policy Statement on Supporting Healthy Ageing for People Who Inject Drugs and/or Receive Pharmacotherapies

Image

Interim Guidance for the Delivery of Medication Assisted Treatment of Opioid Dependence in Response to COVID-19: A National Response

Image

Policy Statement on Methamphetamine Use, Blood Borne Viruses (BBVs) and Sexually Transmissible Infections (STIs)

Image

Policy Statement on Legislative Barriers to Peer Distribution of Sterile Injecting Equipment

Image

Urgent Policy and Funding Needs in the Alcohol and Other Drugs Sector in Response to COVID-19

Submissions

2020

Image

Responding to the Urgent COVID-19 Policy and Funding Needs of the Alcohol and Other Drugs Sector

Image

AIVL Drug Testing Trial Submission

Image

Consultation Paper: Development of the National Preventative Health Strategy

Image

Open Letter Calling for Safe Release of Adults and Children from Prisons and Youth Detention Centres

Image

RACGP Standards of Health Services in Australian Prisons (2nd edition)

Image

Second National Open Letter to Australian Governments on COVID-19 and Prisons and Youth Detention Centres

2019

Image

Healthy Prison Review of the Alexander Maconochie Centre (AMC)

Image

AIVL Drug Testing Trial Submission

Image

AIVL Federal Health Budget 2019–2020 Overview

Image

Developing the Implementation Plans for the National BBV and STI Strategies

Image

Healthy Prison Review of the AMC Submission

Image

Nyxoid Submission 2019

Image

Potential Benefits of Long Acting
Buprenorphine Formulations in
Pharmacotherapy for Opioid Dependence


2018

Image

Joint 1-pager: My Health Record
Opt-out Deadline

Image

Heads Up: 15 November Deadline
to Opt-out of 'My Health Record'